Results 121 to 130 of about 452,167 (205)
Translational molecular imaging and drug development in multiple sclerosis. [PDF]
TheranosticsTay D, Ahmed H, Dawoud A, Salam M, Gobbi L, Grether U, Edelmann MR, Wittwer MB, Collin L, Atz K, Keaney J, Giroud M, Rossi A, Gennari AG, Pagano G, Parrot NJ, Barakovic M, Rominger A, Gebhard C, Ametamey SM, Saindane AM, Liang SH, Haider A. +22 moreeuropepmc +1 more sourceA 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis
, 2015 Jens Kühle, Martin Hardmeier, Giulio Disanto, Konstantin Gugleta, Matyas Ecsedi, Carmen Lienert, Maria Pia Amato, K. Baum, Mathias Buttmann, Antonios Bayas, David Brassat, Bruno Brochet, Christian Confavreux, Gilles Edan, Martti Färkkilâ, S. Fredrikson, Marco Frontoni, Marie D’hooghe, Michael Hutchinson, Jacques De Keyser, BC Kieseier, Tania Kümpfel, Jordi Río, Chris H. Polman, E Roullet, C Stolz, K. Vass, K.P. Wandinger, Ludwig Kappos, the European Long-term Follow-up Study Group in Interferon β-1b in Secondary-progressive Multiple Sclerosis +29 moreopenalex +2 more sourcesAssociation between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis
, 2013 Silvia Rossi, Marco Bozzali, Monica Bari, Francesco Mori, Valeria Studer, Caterina Motta, Fabio Buttari, Mara Cercignani, Paolo Gravina, Nicolina Mastrangelo, Maura Castelli, Raffaele Mancino, Carlo Nucci, Fabrizio Sottile, Sergio Bernardini, Mauro Maccarrone, Diego Centonze +16 moreopenalex +2 more sources
